CHI's first symposium to increase the understanding of its role in performing human immunologic studies

Aug 28 2009

NIH’s National Heart, Lung and Blood Institute’s CENTER FOR HUMAN IMMUNOLOGY (CHI) announces the first Meeting the Human Immunology Challenge Symposium. This two-day meeting will be held September 3-4, 2009 on the NIH Campus.

This symposium is being supported by the Foundation for the National Institutes of Health, with sponsoring partners that include: Agilent, Amgen, BMS, Invitrogen, MedImmune, Novartis, and Pfizer.

There are several goals for this first meeting of the Center for Human Immunology (CHI). One aim is increasing the Institute's understanding of how CHI can play the most effective possible role in performing human immunologic studies in today's academic environment. In this regard, there will be discussions regarding clinical research challenges and opportunities in various areas of expertise.

An equally important goal is to provide information to the larger community on what tools, techniques, clinical, and intellectual resources are available in the CHI, with the hope that clinical/scientific collaboration between intramural NIH researchers and the extramural community can be fostered and developed.

This Symposium will also host representatives from several companies focused on this space as well as leadership from the National Heart, Lung and Blood Institute so it should be an excellent networking opportunity for academics and researchers and health care practitioners alike.